SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-010658
Filing Date
2022-07-13
Accepted
2022-07-12 19:01:38
Documents
13
Period of Report
2022-07-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220706x8k.htm   iXBRL 8-K 30914
  Complete submission text file 0001558370-22-010658.txt   157660

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20220706.xsd EX-101.SCH 3862
3 EX-101.DEF tmb-20220706_def.xml EX-101.DEF 3514
4 EX-101.LAB tmb-20220706_lab.xml EX-101.LAB 17266
5 EX-101.PRE tmb-20220706_pre.xml EX-101.PRE 10069
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220706x8k_htm.xml XML 4793
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 221079913
SIC: 2834 Pharmaceutical Preparations